These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3627287)

  • 61. Substrate and inhibitor binding and translocation by the platelet plasma membrane serotonin transporter.
    Humphreys CJ; Beidler D; Rudnick G
    Biochem Soc Trans; 1991 Feb; 19(1):95-8. PubMed ID: 2037207
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine.
    O'Riordan C; Phillips OM; Williams DC
    J Neurochem; 1990 Apr; 54(4):1275-80. PubMed ID: 2313287
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis.
    Wielosz M; Salmona M; de Gaetano G; Garattini S
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):59-65. PubMed ID: 1012348
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human megakaryocytes cultured in vitro accumulate serotonin but not meta-iodobenzylguanidine whereas platelets concentrate both.
    Tytgat GA; van den Brug MD; Voûte PA; Smets LA; Rutgers M
    Exp Hematol; 2002 Jun; 30(6):555-63. PubMed ID: 12063022
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Upregulation of imipramine binding and serotonin uptake by estradiol in female rat brain.
    Rehavi M; Sepcuti H; Weizman A
    Brain Res; 1987 Apr; 410(1):135-9. PubMed ID: 3580892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes.
    Wennogle LP; Meyerson LR
    Life Sci; 1985 Apr; 36(16):1541-50. PubMed ID: 3982224
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Imipramine binding site. Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membrane.
    Plenge P; Mellerup ET
    Biochim Biophys Acta; 1984 Feb; 770(1):22-8. PubMed ID: 6230106
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Temperature-sensitive conformational changes in [3H]imipramine binding sites and the involvement of sulphur-containing bonds.
    Davis A
    Eur J Pharmacol; 1984 Jul; 102(2):341-7. PubMed ID: 6090163
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Variations in platelets 3H-imipramine binding during two different periods of the year.
    Marazziti D; Lenzi A; Maremmani I; Di Muro A; Castrogiovanni P; Cassano GB
    Chronobiol Int; 1989; 6(4):303-4. PubMed ID: 2627716
    [No Abstract]   [Full Text] [Related]  

  • 70. Dopamine uptake by platelets is selective, temperature dependent and not influenced by the dopamine-D1 or dopamine-D2 receptor.
    Dean B; Copolov DL
    Life Sci; 1989; 45(5):401-11. PubMed ID: 2570336
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of [3H]imipramine binding and [3H]5-HT uptake in human platelets by some natural indoleamine and catecholamine aldehyde condensation products.
    Brusov OS; Fomenko AM; Katasonov AB
    Eur J Pharmacol; 1984 Aug; 103(1-2):191-2. PubMed ID: 6090176
    [No Abstract]   [Full Text] [Related]  

  • 72. Serotonin uptake at 22 degrees C of stored platelets.
    Shimizu T
    Tohoku J Exp Med; 1986 Oct; 150(2):127-33. PubMed ID: 3810639
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of a single oral dose of 3-cyano-imipramine on serotonin uptake and content of platelets in healthy volunteers.
    Kenny M; Lenehan TJ; Lambe R; Darragh A; Brick I; Omer LM
    Psychopharmacology (Berl); 1983; 79(4):304-7. PubMed ID: 6407042
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.
    Rudnick G; Wall SC
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1817-21. PubMed ID: 1347426
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Specific high affinity [3H]imipramine binding sites in rat lung are associated with a non-neuronal uptake site for serotonin.
    Raisman R; Langer SZ
    Eur J Pharmacol; 1983 Oct; 94(3-4):345-8. PubMed ID: 6317406
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
    Dumbrille-Ross A; Tang SW
    Mol Pharmacol; 1983 May; 23(3):607-13. PubMed ID: 6306430
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Heterogeneity of antidepressant binding sites on the recombinant rat serotonin transporter SERT1.
    Schloss P; Betz H
    Biochemistry; 1995 Oct; 34(39):12590-5. PubMed ID: 7548008
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chlorimipramine--but not imipramine--rapidly reduces [3H]imipramine binding in human platelet membranes.
    Mellerup ET; Plenge P
    Eur J Pharmacol; 1986 Jul; 126(1-2):155-8. PubMed ID: 3758160
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Platelets and biogenic amines. 1. Platelets are poor investigative models for dopamine re-uptake.
    Malmgren R
    Psychopharmacology (Berl); 1984; 84(4):480-5. PubMed ID: 6441948
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
    Phillips OM; Wood KM; Williams DC
    Eur J Pharmacol; 1988 Feb; 146(2-3):299-306. PubMed ID: 3371401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.